✦ LIBER ✦

Prospects improve for long-lasting flu vaccine

✍ Scribed by Dolgin, Elie

Book ID: 109932509
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 338 KB
Volume: 16
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm1210-1347

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospects for improved bluetongue vaccin

Prospects for improved bluetongue vaccines

✍ Roy, Polly; Boyce, Mark; Noad, Robert 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 935 KB

Future prospects in the QCD era: For how

Future prospects in the QCD era: For how long will the shell model last?

✍ D.H. Wilkinson 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Development of a single-shot subunit vac

Development of a single-shot subunit vaccine for HIV-1. 5. Programmable in vivo autoboost and long lasting neutralizing response

✍ Jeffrey L. Cleland; Amy Lim; Ann Daugherty; Lorena Barron; Noelyn Desjardin; Eil 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Dramatic efficacy improvement of a DC-ba

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

✍ Stéphanie Delluc; Patricia Hachem; Sylvie Rusakiewicz; Auguste Gaston; Carmen Ma 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 437 KB

Long-term follow-up of allogeneic HSCT f

Long-term follow-up of allogeneic HSCT for CML reveals significant improvement in the outcome over the last decade

✍ Martin Weisser; Georg Ledderose; Hans Jochem Kolb 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 217 KB

Does elective sclerotherapy improve the

Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial

✍ Olivier Ink; Thierry Martin; Thierry Poynard; Marc Reville; Marie-Laure Anciaux; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 931 KB

We conducted a prospective, multicenter, randomized trial to compare the efficacy of sclerotherapy plus propranolol with that of propranolol alone in the prevention of recurrent gastroesophageal bleeding in severely cirrhotic patients. For 2 yr (1987 to 1988) 131 patients (96% of whom were alcoholic